![Meldungen - Europäisches Bewertungsverfahren für die Auffrischimpfung mit dem COVID-19-Impfstoff Janssen gestartet - Paul-Ehrlich-Institut Meldungen - Europäisches Bewertungsverfahren für die Auffrischimpfung mit dem COVID-19-Impfstoff Janssen gestartet - Paul-Ehrlich-Institut](https://www.pei.de/SharedDocs/Bilder/DE/newsroom/hp-meldungen-pm/janssen-booster-ema.jpg?__blob=thumbnail&v=3)
Meldungen - Europäisches Bewertungsverfahren für die Auffrischimpfung mit dem COVID-19-Impfstoff Janssen gestartet - Paul-Ehrlich-Institut
![Johnson & Johnson: Wie wirksam und sicher ist der Impfstoff gegen COVID-19?| Stiftung Gesundheitswissen Johnson & Johnson: Wie wirksam und sicher ist der Impfstoff gegen COVID-19?| Stiftung Gesundheitswissen](https://www.stiftung-gesundheitswissen.de/sites/default/files/2021-06/2021_06_08_tabellen_janssen_erkrankung_symptomatisch.png)
Johnson & Johnson: Wie wirksam und sicher ist der Impfstoff gegen COVID-19?| Stiftung Gesundheitswissen
![Coronavirus: Johnson & Johnson beginnt Phase-3-Studie für Impfstoff gegen Sars-CoV-2 - manager magazin Coronavirus: Johnson & Johnson beginnt Phase-3-Studie für Impfstoff gegen Sars-CoV-2 - manager magazin](https://cdn.prod.www.manager-magazin.de/images/ccc22962-7957-415b-8492-e0a82c60c10e_w1280_r1.77_fpx30.04_fpy48.98.jpg)
Coronavirus: Johnson & Johnson beginnt Phase-3-Studie für Impfstoff gegen Sars-CoV-2 - manager magazin
![Johnson & Johnson: Johnson & Johnson starts phase 3 trial of vaccine; could be available for use by early 2021 - The Economic Times Johnson & Johnson: Johnson & Johnson starts phase 3 trial of vaccine; could be available for use by early 2021 - The Economic Times](https://img.etimg.com/photo/msid-78284241,imgsize-196618/gfgrefe.jpg)
Johnson & Johnson: Johnson & Johnson starts phase 3 trial of vaccine; could be available for use by early 2021 - The Economic Times
IRB APPROVED Sep 24, 2020 INFORMED CONSENT FORM AND HIPAA AUTHORIZATION TITLE: A Randomized, Double-blind, Placebo-controlled Ph
![Trial Dropouts Illustrate Worries For J&J, Other Later Entrants To COVID Vaccine Space :: Pink Sheet Trial Dropouts Illustrate Worries For J&J, Other Later Entrants To COVID Vaccine Space :: Pink Sheet](https://pink.pharmaintelligence.informa.com/-/media/editorial/pink-sheet/2021/02/ps0221jj-crossoverimage2.jpg?rev=22f6109dc74142519a59a92a07573778&hash=F3A1E05989A8849F8F32A3AA4BD35311)
Trial Dropouts Illustrate Worries For J&J, Other Later Entrants To COVID Vaccine Space :: Pink Sheet
![Opinion | I got the placebo in the Johnson & Johnson vaccine trial. Here's my full journey. - The Washington Post Opinion | I got the placebo in the Johnson & Johnson vaccine trial. Here's my full journey. - The Washington Post](https://arc-anglerfish-washpost-prod-washpost.s3.amazonaws.com/public/Q5LHJRESLII6XJ2OD5GPRH6ZJA.jpg)
Opinion | I got the placebo in the Johnson & Johnson vaccine trial. Here's my full journey. - The Washington Post
![How Effective Is the Johnson & Johnson COVID-19 Vaccine? Here's What You Should Know | UC San Francisco How Effective Is the Johnson & Johnson COVID-19 Vaccine? Here's What You Should Know | UC San Francisco](https://www.ucsf.edu/sites/default/files/styles/half__image/public/2021-03/COVID19-J%26JVaccine-vial-syringe-Ramirez.jpg)
How Effective Is the Johnson & Johnson COVID-19 Vaccine? Here's What You Should Know | UC San Francisco
![A week after Covid-19 vaccine trial goes on pause, Johnson & Johnson and FDA won't reveal critical details | CNN A week after Covid-19 vaccine trial goes on pause, Johnson & Johnson and FDA won't reveal critical details | CNN](https://media.cnn.com/api/v1/images/stellar/prod/190213093957-johnson-johnson-auris-health-restricted.jpg?q=x_4,y_0,h_2129,w_3784,c_crop/h_144,w_256)
A week after Covid-19 vaccine trial goes on pause, Johnson & Johnson and FDA won't reveal critical details | CNN
![Johnson & Johnson pauses Covid vaccine trial over participant's 'unexplained illness' | Coronavirus | The Guardian Johnson & Johnson pauses Covid vaccine trial over participant's 'unexplained illness' | Coronavirus | The Guardian](https://i.guim.co.uk/img/media/05d6e53925bed3fe6cc6ef80c9a2bffac05930cc/0_45_1667_1000/master/1667.jpg?width=1200&height=900&quality=85&auto=format&fit=crop&s=c7f695ab19799e818e6e5181728b8ae0)
Johnson & Johnson pauses Covid vaccine trial over participant's 'unexplained illness' | Coronavirus | The Guardian
![J&J, in rebuttal to pricing criticism, says antidepressant Spravato is cost-effective | Fierce Pharma J&J, in rebuttal to pricing criticism, says antidepressant Spravato is cost-effective | Fierce Pharma](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1558451480/JNJIOffice3.jpg/JNJIOffice3.jpg?VersionId=3H1L37XlhiGKebYbCPQYNEmzj9rKw2aM)
J&J, in rebuttal to pricing criticism, says antidepressant Spravato is cost-effective | Fierce Pharma
![Debatte um Impfstoff von Astrazeneca - Was über Wirksamkeit und Nebenwirkungen bekannt ist | deutschlandfunk.de Debatte um Impfstoff von Astrazeneca - Was über Wirksamkeit und Nebenwirkungen bekannt ist | deutschlandfunk.de](https://assets.deutschlandfunk.de/FILE_f0b416136f4cb78ccefe43057c9c5224/original.jpg?t=1613735057190)